How Bio-Techne is bridging cancer research, spatial biology, and diagnostics

Bio‑Techne is evolving its approach to support the rapidly changing needs of cancer research. In this SelectScience interview, Bio‑Techne leaders Steve Crouse and Steve Silverman share how the company’s newly launched portfolio is designed to support the entire oncology journey, from early discovery through to clinical application. They discuss how bringing together discovery tools, spatial biology technologies, and diagnostic solutions enables researchers and clinicians to generate deeper insights and turn science into real‑world impact.

This video was filmed at AACR Annual Meeting 2026.